These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 29566483)

  • 1. Sputum Active Polymyxin Lipopeptides: Activity against Cystic Fibrosis Pseudomonas aeruginosa Isolates and Their Interactions with Sputum Biomolecules.
    Schneider-Futschik EK; Paulin OKA; Hoyer D; Roberts KD; Ziogas J; Baker MA; Karas J; Li J; Velkov T
    ACS Infect Dis; 2018 May; 4(5):646-655. PubMed ID: 29566483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An "Unlikely" Pair: The Antimicrobial Synergy of Polymyxin B in Combination with the Cystic Fibrosis Transmembrane Conductance Regulator Drugs KALYDECO and ORKAMBI.
    Schneider EK; Azad MA; Han ML; Tony Zhou Q; Wang J; Huang JX; Cooper MA; Doi Y; Baker MA; Bergen PJ; Muller MT; Li J; Velkov T
    ACS Infect Dis; 2016 Jul; 2(7):478-88. PubMed ID: 27626100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Octapeptin C4 and polymyxin resistance occur via distinct pathways in an epidemic XDR Klebsiella pneumoniae ST258 isolate.
    Pitt ME; Cao MD; Butler MS; Ramu S; Ganesamoorthy D; Blaskovich MAT; Coin LJM; Cooper MA
    J Antimicrob Chemother; 2019 Mar; 74(3):582-593. PubMed ID: 30445429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.
    Hill D; Rose B; Pajkos A; Robinson M; Bye P; Bell S; Elkins M; Thompson B; Macleod C; Aaron SD; Harbour C
    J Clin Microbiol; 2005 Oct; 43(10):5085-90. PubMed ID: 16207967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "Superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators.
    Hussein MH; Schneider EK; Elliott AG; Han M; Reyes-Ortega F; Morris F; Blastovich MAT; Jasim R; Currie B; Mayo M; Baker M; Cooper MA; Li J; Velkov T
    Microb Drug Resist; 2017 Jul; 23(5):640-650. PubMed ID: 27935770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of artificial sputum medium to test antibiotic efficacy against Pseudomonas aeruginosa in conditions more relevant to the cystic fibrosis lung.
    Kirchner S; Fothergill JL; Wright EA; James CE; Mowat E; Winstanley C
    J Vis Exp; 2012 Jun; (64):e3857. PubMed ID: 22711026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of heteroresistance to polymyxin B among carbapenem-susceptible and -resistant Pseudomonas aeruginosa.
    Hermes DM; Pormann Pitt C; Lutz L; Teixeira AB; Ribeiro VB; Netto B; Martins AF; Zavascki AP; Barth AL
    J Med Microbiol; 2013 Aug; 62(Pt 8):1184-1189. PubMed ID: 23699064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single and combination antibiotic susceptibilities of planktonic, adherent, and biofilm-grown Pseudomonas aeruginosa isolates cultured from sputa of adults with cystic fibrosis.
    Aaron SD; Ferris W; Ramotar K; Vandemheen K; Chan F; Saginur R
    J Clin Microbiol; 2002 Nov; 40(11):4172-9. PubMed ID: 12409393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures.
    Tré-Hardy M; Vanderbist F; Traore H; Devleeschouwer MJ
    Int J Antimicrob Agents; 2008 Apr; 31(4):329-36. PubMed ID: 18280117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effect of membrane-active peptides polymyxin B and gramicidin S on multidrug-resistant strains and biofilms of Pseudomonas aeruginosa.
    Berditsch M; Jäger T; Strempel N; Schwartz T; Overhage J; Ulrich AS
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5288-96. PubMed ID: 26077259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Battacin (Octapeptin B5), a new cyclic lipopeptide antibiotic from Paenibacillus tianmuensis active against multidrug-resistant Gram-negative bacteria.
    Qian CD; Wu XC; Teng Y; Zhao WP; Li O; Fang SG; Huang ZH; Gao HC
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1458-65. PubMed ID: 22183171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Low-Molecular-Weight Alginate Oligosaccharide Disrupts Pseudomonal Microcolony Formation and Enhances Antibiotic Effectiveness.
    Pritchard MF; Powell LC; Jack AA; Powell K; Beck K; Florance H; Forton J; Rye PD; Dessen A; Hill KE; Thomas DW
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial activity of synthetic cationic peptides and lipopeptides derived from human lactoferricin against Pseudomonas aeruginosa planktonic cultures and biofilms.
    Sánchez-Gómez S; Ferrer-Espada R; Stewart PS; Pitts B; Lohner K; Martínez de Tejada G
    BMC Microbiol; 2015 Jul; 15():137. PubMed ID: 26149536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rediscovering the octapeptins.
    Velkov T; Roberts KD; Li J
    Nat Prod Rep; 2017 Mar; 34(3):295-309. PubMed ID: 28180225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinically Relevant Concentrations of Polymyxin B and Meropenem Synergistically Kill Multidrug-Resistant
    Wickremasinghe H; Yu HH; Azad MAK; Zhao J; Bergen PJ; Velkov T; Zhou QT; Zhu Y; Li J
    Antibiotics (Basel); 2021 Apr; 10(4):. PubMed ID: 33918040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymyxin B and ethylenediaminetetraacetic acid act synergistically against
    Hale SJM; Cameron AJ; Lux CA; Biswas K; Kim R; O'Carroll M; Harris PWR; Douglas RG; Wagner Mackenzie B
    Microbiol Spectr; 2024 Feb; 12(2):e0170923. PubMed ID: 38168683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung.
    Harrington NE; Sweeney E; Alav I; Allen F; Moat J; Harrison F
    J Vis Exp; 2021 Jan; (167):. PubMed ID: 33554970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomics Study of the Synergistic Killing of Polymyxin B in Combination with Amikacin against Polymyxin-Susceptible and -Resistant Pseudomonas aeruginosa.
    Hussein M; Han ML; Zhu Y; Zhou Q; Lin YW; Hancock REW; Hoyer D; Creek DJ; Li J; Velkov T
    Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31611351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of colistin against biofilm by Pseudomonas aeruginosa is significantly improved under "cystic fibrosis-like" physicochemical conditions.
    Pompilio A; Crocetta V; Pomponio S; Fiscarelli E; Di Bonaventura G
    Diagn Microbiol Infect Dis; 2015 Aug; 82(4):318-25. PubMed ID: 26004353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of antibacterial activities of polymyxin B and colistin against multidrug resistant Gram negative bacteria.
    Doymaz MZ; Karaaslan E
    Infect Dis (Lond); 2019 Sep; 51(9):676-682. PubMed ID: 31298061
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 30.